Catalogue Number: 361584-USB
| Manufacturer: | United States Biological |
| Physical state: | Supplied as a liquid in PBS, pH 7.2, 0.02% Proclin-300. |
| Type: | Monoclonal Primary Antibody - Unconjugated |
| Shipping Condition: | Blue Ice |
| Unit(s): | 200 ug |
| Host name: | Human |
| Clone: | 4D5-8 (trastuzumab) (recomb) |
| Isotype: | IgG1, kappa |
| Immunogen: | A431 cells (human epidermoid carcinoma) (over)expressing EGFR. |
| Application: | ELISA, FC, IHC |
Description: Recombinant monoclonal antibody to ErbB2 with variable regions (i.e. specificity) from the therapeutic antibody 4D5-8 (trastuzumab). Manufactured using a proprietary recombinant platform technology. Not for therapeutic use; this is a research grade biosimilar. Oncogenic protein Her-2/neu (erbB-2), is a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder. This antibody binds to erbB-2/Her-2/neu has therapeutic indications particularly in the treatment of breast cancer (c.f. Herceptin). It can also be used to detect HER-2 by flow cytometry or IHC.
2064
ERBB2
P04626
Recognizes ErbB-2. Species Crossreactivity: human
Protein A purified
Recombinant Monoclonal